If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosslyn Data Regulatory News (RDT)

Share Price Information for Rosslyn Data (RDT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.263%)
Open: 9.75
High: 9.75
Low: 9.75
Prev. Close: 9.75
RDT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

4 Mar 2024 07:00

RNS Number : 3633F
Rosslyn Data Technologies PLC
04 March 2024
 

4 March 2024 

 

Rosslyn Data Technologies plc 

("Rosslyn" or the "Company") 

 

Trading Update

 

Rosslyn (AIM: RDT), the provider of a leading cloud-based enterprise data analytics platform, provides the following update on trading for the year ending 30 April 2024.

 

The Company is pleased to report that since the interim results announcement on 25 January 2024, the Company has continued to expand its total pipeline, which remains larger than at the same point last year. Importantly, discussions with sizable new partners have continued to progress. Whilst the Board remains hopeful that at least one of these contracts will be signed before the current financial year end, the Board recognises that the size and nature of the opportunities has meant that there have been extended timeframes for interactions with partners of this scale. As such, timelines for concluding these contracts are correspondingly more protracted than originally anticipated and the Board now expects that only a limited amount of revenue from these contracts will be recognised in the current financial year. Consequentially, the Company expects to report revenues for the year ending 30 April 2024 in the range of approximately £2.8m-£3.0m, with a corresponding adj. EBITDA loss of between approximately £2.6m-£2.8m. Cash and cash equivalents as at 29 February 2024 were approximately £800k. The Board continues to closely monitor cash to ensure that the Company has sufficient resources to execute its growth strategy. Cash burn and customer acquisition cost are expected to reduce as the Company converts its pipeline in the coming weeks and the Company is seeking to improve contract payment terms to include upfront payments. 

 

The Board is encouraged by the strengthening of the customer and partner engagement that the Company is experiencing and is confident of securing further sizeable contracts in the near-term. It also looks forward to the launch of Rosslyn's next-generation generative AI module, which has received excellent feedback from customers during the trial phase and which offers a transformational opportunity. Accordingly, whilst the immediate period is not without challenges, the Board remains confident in the Company's prospects.

 

The Company will keep the market updated on its progress.

 

This announcement contains inside information.

 

 

Enquiries

 

Rosslyn

Paul Watts, Chief Executive Officer

James Appleby, Chairman

+44 (0)20 3285 8008

 

Cavendish Capital Markets Limited (Nominated adviser and Broker)

Stephen Keys/Camilla Hume/George Lawson

+44 (0)20 7220 0500

Gracechurch Group (Financial PR)

Claire Norbury/Anysia Virdi

+44 (0)20 4582 3500

 

 

About Rosslyn

 

Rosslyn (AIM: RDT) provides an award-winning spend analytics and predictive analytics platform. The Rosslyn Platform helps organizations with diverse supply chains mitigate risk and make informed strategic decisions. It leverages automated workflows, artificial intelligence and machine learning to extract and consolidate procurement data providing visibility of complex supplier data, enabling supplier spend savings and delivering rapid ROI. For more information visit www.rosslyn.ai

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKNBBQBKDNNK
Date   Source Headline
15th Jun 20207:00 amRNSGrant of Options
12th Jun 20204:13 pmRNSHolding(s) in Company
11th Jun 20203:07 pmRNSHolding(s) in Company
9th Jun 20208:40 amRNSHolding(s) in Company
2nd Jun 20208:07 amRNSHolding(s) in Company
1st Jun 20208:56 amRNSHolding(s) in Company
29th May 20209:43 amRNSHolding(s) in Company
29th May 20208:43 amRNSHolding(s) in Company
28th May 202012:32 pmRNSHolding(s) in Company
28th May 202010:39 amRNSHolding(s) in Company
27th May 202012:06 pmRNSResult of General Meeting
19th May 20208:19 amRNSHolding(s) in Company
18th May 20202:48 pmRNSHolding(s) in Company
15th May 20202:49 pmRNSHolding(s) in Company
7th May 20203:53 pmRNSPlacing to Raise £7.3m and Trading Update
10th Feb 202010:56 amRNSDirector/PDMR Shareholding
4th Feb 20205:26 pmRNSDirector/PDMR Shareholding
15th Jan 20209:17 amRNSPDMR Shareholding
14th Jan 20204:41 pmRNSSecond Price Monitoring Extn
14th Jan 20204:36 pmRNSPrice Monitoring Extension
14th Jan 20207:01 amRNSContract Win
14th Jan 20207:00 amRNSHalf-year Report
8th Jan 20207:00 amRNSContract Wins
11th Dec 20197:00 amRNSTrading Update
26th Nov 20198:57 amRNSHolding(s) in Company
25th Nov 20196:17 pmRNSDirector/PDMR Shareholding
17th Oct 20192:01 pmRNSResult of AGM
17th Oct 20197:00 amRNSBoard Changes
24th Sep 20197:00 amRNSAcquisition
17th Sep 20197:00 amRNSFinal Results
20th Aug 20195:28 pmRNSHolding(s) in Company
25th Jul 20194:58 pmRNSDirector/PDMR Shareholding
9th Jul 20197:00 amRNSContract Win
17th Jun 20193:04 pmRNSExercise of Options, Director/PDMR Shareholding
30th May 20192:53 pmRNSDirector/PDMR Shareholding
29th May 20197:00 amRNSTrading Update
20th May 20197:00 amRNSBoard Changes
11th Apr 20197:00 amRNSBoard Appointment
9th Apr 20197:00 amRNSLoan Refinancing
25th Feb 20191:54 pmRNSHolding(s) in Company
11th Feb 20197:00 amRNSContract Wins
11th Dec 20183:46 pmRNSHolding(s) in Company
5th Dec 20183:25 pmRNSHolding(s) in Company
5th Dec 20183:23 pmRNSHolding(s) in Company
30th Nov 201812:38 pmRNSDirector/PDMR Shareholding
26th Nov 20187:00 amRNSHalf-year Report
7th Nov 20185:29 pmRNSResult of AGM
5th Nov 20188:08 amRNSHolding(s) in Company
30th Oct 20189:38 amRNSAGM Statement
30th Oct 20187:00 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.